
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Sponsored and produced by Focus Limited.
almost 22 years ago
The Year Payers Stopped Threateningalmost 22 years ago
Filling the Gaps





